Home Medical Devices Europe Diabetes Devices Market Size, Demand, Share, Forecast to 2030

Europe Diabetes Devices Market Size, Share & Trends Analysis Report By Type (Blood Glucose Monitoring Devices, Insulin Delivery Devices), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Diabetes Clinics/Centers, Online Pharmacies, Others), By Application (Hospitals, Homecare, Diagnostics Centers) and By Country(U.K., Germany, France, Spain, Italy, Russia, Nordic, Benelux, Rest of Europ) Forecasts, 2022-2030

Report Code: SRMD3217DR
Last Updated : Jan 03, 2024
Author : Straits Research
Starting From
USD 1850
Buy Now

Market Segmentation

  • Europe Diabetes Devices Market, By Type (2020-2030)
    1. Blood Glucose Monitoring Devices
    2. Insulin Delivery Devices
  • Europe Diabetes Devices Market, By Distribution Channel (2020-2030)
    1. Hospital Pharmacies
    2. Retail Pharmacies
    3. Diabetes Clinics/Centers
    4. Online Pharmacies
    5. Others
  • Europe Diabetes Devices Market, By Application (2020-2030)
    1. Hospitals
    2. Homecare
    3. Diagnostics Centers

    Related Reports

    Global Report
    The Total Addressable Market (TAM) for Beauty Device was valued at USD 59.09 billion in 2022. It is projected to reach USD 157.91 billion by 2031, growing at a CAGR of 11.54% during the forecast period (2023–2031). The face, hair, hands, and f
    Buy Now
    Global Report
    The global diabetes care devices market size was valued at USD 52,692 million, which is expected to reach USD 87,150 million at a CAGR of 6% during the forecast period (2022–2030). Factors such as Prevalence of Diagnosed Cases Fostering Researc
    Buy Now
    Global Report
    The global ENT devices market size was valued at USD 23.13 billion in 2022. It is estimated to reach USD 33.49 billion by 2031, growing at a CAGR of 4.2% during the forecast period (2023–2031). A rise in the prevalence of hearing loss/impairmen
    Buy Now
    Global Report
    The global epilepsy devices market size was valued at USD 1,760 million in 2022. It is estimated to reach USD 3,893 million by 2031, growing at a CAGR of 9.22% during the forecast period (2023–2031). In epilepsy, aberrant brain activity r
    Buy Now

    Purchase Benefits

    • Eligible for a free updated report next year
    • Completely customizable scope
    • 30% discount on your next purchase
    • Dedicated account manager
    • Query resolution within 24 hours
    • Permission to print the report


    We are featured on :